Status:

UNKNOWN

The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia

Lead Sponsor:

Zekai Tahir Burak Women's Health Research and Education Hospital

Conditions:

Preeclampsia

Eclampsia

Eligibility:

FEMALE

18-40 years

Brief Summary

Neutrophil/lymphocyte ratio (NLR) is a marker of systemic inflammation and endothelial dysfunction. In recent years, it has been reported that the individual components of the differential white cell ...

Detailed Description

In recent years, have been reported that the individual components of the differential white cell count, specifically the neutrophil and lymphocyte counts, may have clinical utility in predicting dise...

Eligibility Criteria

Inclusion

  • pregnant women who developing preeclampsia eclampsia at pregnancy

Exclusion

  • Known chronically maternal disease multiple pregnancy older than 40 years old

Key Trial Info

Start Date :

May 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2014

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT01856387

Start Date

May 1 2013

End Date

May 1 2014

Last Update

March 18 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zekai Tahir Burak Maternity Teaching Hospital

Ankara, Turkey (Türkiye)